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Abstract
Major depression in the elderly is associated with brain structural changes and vascular lesions. Changes in the subcortical
regions of the limbic system have also been noted. Studies examining hippocampus volumetric differences in depression
have shown variable results, possibly due to any volume differences being secondary to local shape changes rather than
differences in the overall volume. Shape analysis offers the potential to detect such changes. The present study applied
spherical harmonic (SPHARM) shape analysis to the left and right hippocampi of 61 elderly subjects with major depression
and 43 non-depressed elderly subjects. Statistical models controlling for age, sex, and total cerebral volume showed a
significant reduction in depressed compared with control subjects in the left hippocampus (F1,103=5.26; p=0.0240) but not
right hippocampus volume (F1,103=0.41; p=0.5213). Shape analysis showed significant differences in the mid-body of the
left (but not the right) hippocampus between depressed and controls. When the depressed group was dichotomized into
those whose depression was remitted at time of imaging and those who were unremitted, the shape comparison showed
remitted subjects to be indistinguishable from controls (both sides) while the unremitted subjects differed in the midbody
and the lateral side near the head. Hippocampal volume showed no difference between controls and remitted subjects but
nonremitted subjects had significantly smaller left hippocampal volumes with no significant group differences in the right
hippocampus. These findings may provide support to other reports of neurogenic effects of antidepressants and their
relation to successful treatment for depressive symptoms.
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Introduction
The hippocampus plays a significant role in emotion processing
with neural connections to key brain regions, including the
thalamus, amygdala, basal ganglia, and prefrontal cortex [1,2].
Structural imaging studies examining hippocampal volumes in
depressed adults have been mixed; some report that volumes are
smaller in depressed groups [3–7], while others have not found
such a difference [8–10]. A more consistent finding is that smaller
hippocampal volumes are seen in subjects with recurrent
depression [4,11] or earlier age of depression onset [4,10,11],
suggesting that duration of depression, particularly untreated
depression [4], may affect hippocampal volumes.
Similar results are seen in studies specifically examining depressed
elderly populations. Some have found that depressed elders exhibit
smaller hippocampal volumes and early age of onset is associated
with smaller volumes [12,13], but others have not found such
relationships [14–16]. Smaller hippocampal volumes also appear to
beassociated with a lowerprobability of remission of depression with
treatment [17]. Further, smaller left hippocampus volumes can be
associated with increased risk of dementia [18].
Thus, while the hippocampus plays a role in the broader neural
circuit which modulates mood and emotion, volumetric differences
have not been consistently identified in depressed populations.
Although there may be many factors that contribute to these
different conclusions, one factor may be that only specific subregions
of the hippocampus are affected in depression. If this is correct, there
may not be a difference between depressed and nondepressed
subjects in hippocampal volume, but hippocampi from these two
groups could differ in shape so that local features could be larger in
the hippocampus but with compensating negative differences in
other regions. Analyses of hippocampal shape have been successfully
used in studies of schizophrenia [19–21] and Alzheimer’s disease
[22–24], and also in a study examining younger adults with
depression [8]. In this study we examined the shape-based
differences between a group of subjects with late-life depression
and a group of non-depressed comparison subjects.
Methods
Subjects and Clinical Evaluation
All subjects were recruited from individuals enrolled in the
Conte Center for the Neuroscience of Depression at Duke
University. Subjects were age 60 years or older; exclusion criteria
included psychiatric diagnoses other than Major Depressive
Disorder, including substance abuse or dependence, primary
neurological disease including dementia, and contraindications to
magnetic resonance imaging (MRI). The presence of comorbid
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ment if the evaluating clinician determined they were secondary to
the depression diagnosis.
At time of enrollment into the Conte Center, depressed subjects
met DSM-IV criteria for Major Depression. This diagnosis, and
the absence of exclusionary diagnoses, was evaluated with the
NIMH Diagnostic Interview Schedule (DIS) [25] which assessed
major depression and age of onset of first depressive episode,
enriched with items assessing lifetime history of psychosis, mania,
anxiety disorders, and substance abuse or dependence. The
presence of a diagnosis of Major Depression and absence of other
psychiatric diagnoses including post-traumatic stress disorder were
confirmed through a clinical interview with a geriatric psychiatrist.
The clinical interview also assessed for a history of dementia or
cognitive and functional deficits supporting such a diagnosis.
Individuals with a diagnosis of dementia or where it was suspected
were not enrolled.
Nondepressed control subjects were community volunteers with
a non-focal neurological examination and no evidence for
depression or other neuropsychiatric disease on the DIS. The
study was approved by the Duke University Health System
Institutional Review Board, and all subjects provided written
informed consent.
After enrollment in the Conte Center, depressed subjects
received antidepressant treatment provided by a study geriatric
psychiatrist. This algorithm-based treatment was personalized to
the individual subject and followed the Duke STAGED approach
[26]. In this treatment algorithm, all commercially available
antidepressant medications were available. Typically treatment
begins with a selective serotonin reuptake inhibitor, unless an
individual’s past history shows a history of lack of response or
intolerance to that class of drug. Antidepressant medication use in
the month prior to MRI was reviewed.
In addition to the use of the DIS for confirming the clinical
diagnosis of Major Depression, demographic data was obtained
through subject interview. Depression severity at time of MRI was
assessed using the clinician-rated Montgomery-Asberg Depression
Rating Scale (MADRS) [27]. The Mini-Mental State Examination
(MMSE) [28] was used to assess global cognitive function; subjects
who scored less than a 24 were excluded.
Image Acquisition
All subjects were screened for any condition where MRI was
contraindicated. Subjects were imaged with a 3.0 Tesla whole-
body MRI system (Trio, Siemens Medical Systems) using an 8-
channel, receive-only volumetric radiofrequency coil. Padding was
used to minimize motion of the head. The scanner alignment light
was used to adjust the head tilt and rotation so that the axial plane
lights were aligned just above the orbits and the sagittal lights were
aligned with the center of the nose. A rapid three-plane localizer
scan was acquired to confirm the alignment. The imaging protocol
included a 3-dimensional, T1-weighted turbo-flash pulse sequence
with imaging parameters: TR/TE/Flip=22/7/25u, 256 mm
field-of-view, 160 slices, 1 mm by 1 mm by 1 mm cubic voxel
dimension, pixel bandwidth=100 Hz. This data was used to
estimate the hippocampus boundary as discussed below.
Hippocampus Boundary Determination
The MR images were transferred to the Neuropsychiatric
Imaging Research Laboratory (NIRL), located at Duke University
Medical Center, for processing. Hippocampal volumes were
determined using the GRID Program that was developed at
NIRL and has been described previously [29,30]. GRID allows for
semi-automated region tracing and determination of region-of-
interest (ROI) volumes and boundaries.
The method for defining the hippocampal perimeter has been
previously described [29]. On all slices, tracing began along the
most inferior border of the main body of the hippocampus, and
then moved laterally along the border between the hippocampus
and the inferior lateral ventricles. Along the medial and superior
borders, tracing included any thin strips of white matter along the
lateral or superior surface. Pockets of cerebrospinal fluid were
excluded; blood vessels were transected unless they were
prominent or did not extend into the hippocampal body. If
motion, poor contrast, or other factors rendered any one slice
unreadable, a volume for that slice was generated by averaging the
volumes from the previous and subsequent slices. If the first or last
slices were unreadable, or if two middle slices were unreadable, the
subject was excluded from analysis.
On each scan, tracing began with the most posterior coronal
slice, then proceeded anteriorly. Measurement of the hippocampus
began when the pulvinar nucleus of the thalamus obscured the
crura fornicis; if the crus was only obscured on one side, then only
that side was measured. On the first few slices, the lateral body of
the hippocampus appears as a rough oval, which narrows medially
into a thin strip of gray matter that curves downwards along the
border of the cistern. The fimbria, which extends from the
superior surface of the hippocampus across the CSF into the white
matter above, was transected at its narrowest point. Along the
medial border of the hippocampus, the thin strip of gray matter
was cut at its narrowest point, and tracing then continued around
the hippocampal body to the starting point.
On more anterior slices, the amygdala begins to appear just
superior to the hippocampus, which roughly resembles a kidney in
shape, with no external connections. The amygdala-hippocampal
transition zone appears as a diffuse area of gray matter between
the anterior portion of the hippocampus and the posterior portion
of the amygdala; as with the fimbria, this area was transected at its
narrowest point, which was usually found between the inferior
lateral ventricles and the cistern. Continuing anteriorly, the
inferior lateral ventricles gradually shift from a vertical to a
horizontal orientation, but remain superior to the hippocampus.
The anterior border of the hippocampus was defined as the slice
on which the inferior lateral ventricles appeared horizontally
without any body of gray matter visible below them.
All image analysis technicians received extensive training by
experienced analysts. Reliability was established by repeated
measurements on 10 MR scans. Intraclass correlation coefficients
(ICC’s) attained were as follows: left hippocampus=0.899, right
hippocampus=0.798.
Hippocampus Shape Analysis
The 3D hippocampal shape analysis is based on the use of
spherical harmonic basis functions (SPHARM) to fit the
hippocampus boundary. The shape analysis algorithm used in
this study was proposed and described in detail in [20,31]. A
schematic view of the shape analysis process is shown in Figure 1.
The first step in the algorithm is to identify the correspondences
among the surfaces of hippocampi. At first, the binary images that
contain the surface points that were determined by the boundary
identification process described above were pre-processed to fill
small holes and minimally smoothed. At this point, then, the
surface was described by the vertexes of the (cubic) voxels on the
surface. A triangulation mesh was then generated from each
binary image by dividing each exterior voxel face into two
triangles. A spherical parameterization was then computed for the
triangulation mesh using a distortion minimizing spherical
Hippocampus Shape Analysis
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the mesh and its parameterization using straightforward fitting to
spherical harmonic functions up to the twelfth degree. The cut-off
at the twelfth degree was determined by examination of residuals
to the fits to have the lowest degree that would adequately describe
the shape. By aligning the first order ellipsoids of all the
parameterizations, the correspondences across all surfaces were
established. All parameterizations were sampled into triangulated
meshes. The triangulated meshes were then spatially aligned using
a rigid transformation. To offset the effects of different head sizes,
the surfaces were scaled according the corresponding head size.
Statistical Methods
All statistical analyses, except shape analyses, were performed
using SAS 8.2 (SAS Institute, Cary, NC). Demographic variables
and clinical measures were compared using pooled, two-tailed t-
tests for continuous variables and chi-square models for categorical
variables. Analysis of group differences in left and right
hippocampal volume were modeled using the GLM procedure,
which covaried for age, sex, and total cerebral volume.
Using a MADRS score of less than 10 as a definition of
remission [32], we then dichotomized the depressed cohort into
those currently remitted, and those who were not. This resulted in
a trichotomous diagnostic variable (nondepressed, depressed-
remitted, and depressed-nonremitted). We tested for differences
between comparison subjects, remitted depressed, and nonre-
mitted depressed subjects using analysis of covariance (ANCOVA).
We repeated the previous models, replacing the previous
dichotomous diagnosis variable with this new trichotomous
variable. Finally, we used the least squared means approach to
identify significant differences between groups.
For the shape analysis statistical methods, the final shape
description consisted of the coordinates of the corresponding
points (appropriately scaled). The null hypothesis is that the
distribution of the spatial locations at each surface point is the
same for every subject regardless of the group. Group differences
between two groups of surfaces were tested using a multivariate
metric: Hotelling’s T-squared test which is a multivariate version
of Student’s t statistic. The analysis generated a raw (unadjusted
for multiple comparisons) significance map showing raw p-values
exceeding 0.05 across the surface. The distance of the two mean
surfaces of the two groups were also generated.
To quantitatively measure the global shape difference, the
global average deviation between the mean surfaces of the two
groups as well as the near maximal distance (95%) between the
mean surfaces of the two groups (average and maximal distance
across the whole surface) was calculated and tested with a two
tailed t-test. This analytic approach was used first for comparisons
between depressed and nondepressed comparison subjects, but
then also paired comparisons between nondepressed, depressed
remitted and depressed non-remitted subjects.
To present the shape differences we incorporated our results
into a single informative visualization shown in Figure 2 and
Figure 3, where the maps in Figure 3 that show the distance from
the mean surface of the group A to the mean surface of the group
B are masked by the significance maps, and displayed in
anatomical context in a corresponding T1-weighted MRI scan
in Figure 2. In this study, group A was the control, group B was
the depressed patients. Thus, this visualization shows three kinds
of information at a specific location on the surface:
1. The magnitude of the distance between the mean shapes of group A and
group B: White color is used where the magnitudes are zero.
The color gets darker as the magnitudes of the distance
increase. The magnitude is in millimeters.
2. The direction of the distances: The distance is positive if the mean
surface of group A is protruding outside of the mean surface of
group B; the distance is negative if the mean surface of group A
is shrinking below the mean surface of group B. Positive
distances are color-coded by blue and negative distances are
color-coded by red.
3. The significance map: The distances are set to zero wherever the
raw p-value exceeds 0.05 and the color is set to white at that
location. In other words, surface locations are in white if the
Figure 1. Shape analysis process.
doi:10.1371/journal.pone.0001837.g001
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magnitude of the distance. Therefore, only the distances which
are statistically significant are visualized in this illustration.
Results
This sample included 43 nondepressed comparison subjects and
61 depressed subjects. There was no difference in sex represen-
tation (depressed: 60.7% female, 37/61; nondepressed: 67.4%
female, 29/43; x
2=0.5009, p=0.4791), although the nonde-
pressed population was older (depressed: 65.9y, SD=5.5y;
nondepressed: 69.0y, SD=5.5y; t=2.87, 102 df, p=0.0048).
There was no difference in MMSE score between the groups
(depressed: 28.4, SD=2.2; nondepressed: 28.7, SD=1.5; t=0.89,
102 df, p=0.3748). The depressed cohort on average had a mild
level of depression severity at time of imaging (MADRS=16.1,
SD=10.7, range 0–44), with a mean age of first depressive episode
onset of 39.3 years (range=4–76 years, SD=19.9 years).
We also reviewed what antidepressant medications depressed
subjects had been taking over the month before the MRI. 29
(47.5%) were taking a serotonin reuptake inhibitor (SSRI), 15
(24.6%) were taking venlafaxine, 9 (14.8%) were taking bupropion,
5 (8.2%) were on nortriptyline, 1 (1.6%) was on mirtazapine, and 7
(11.5%) were not on an antidepressant medication. 5 people
(8.2%) were on two antidepressants. Per exclusion criteria, no
nondepressed comparison subject was taking an antidepressant.
Depressed subjects generally exhibited smaller hippocampal
volumes than did nondepressed subjects, although in univariate
analyses of unadjusted volumes, these differences were not
statistically significant (left hippocampus: depressed=3.42mL,
SD=0.54mL; nondepressed=3.55mL, SD=0.48mL; t=1.29,
102 df, p=0.1994; right hippocampus: depressed=3.65mL,
SD=0.55mL; nondepressed=3.66mL, SD=0.57mL; t=0.08,
102 df, p=0.9236). The models controlling for age, sex, and total
cerebral volume showed a significant difference between depressed
and nondepressed subjects in left (F1,103=5.26; p=0.0240) but not
right hippocampus volume (F1,103=0.41; p=0.5213).
The visualization demonstrating group differences between
control and depressed subjects is overlaid on a pair of
representative hippocampi in Figure 3. The regional differences
are most noticeable in the left hippocampus, on the superior side,
approximately midway down the body. The area where there is a
shape difference shows a central region of contraction (smaller in
depressed than nondepressed subjects) flanked by regions of
expansion (larger in depressed than nondepressed subjects).
Although the location of these anatomic changes cannot be
specifically pinpointed, in the depressed cohort these changes
correspond to a contraction in the dentate gyrus and possibly CA4
region, with areas of expansion in the subiculum and the CA2-3
region.
The global shape difference metrics yielded no significant
difference in the average difference or the maximal deviation
between the average surface for the two groups (p.0.1 for all
measures for left and right hippocampus) indicating that the
differences shown are local.
Three-Way Comparisons
To further investigate the shape difference of remitted patients,
depressed subjects were divided into two groups: currently
remitted (N=24) and non-remitted (37). See Table 1 for
demographic differences between these two groups and nonde-
pressed comparison subjects. Of the remitted subjects, 13 (54.2%)
were on a SSRI, 5 (20.8%) on venlafaxine, 2 (8.3%) on bupropion,
2 (8.3%) on nortriptyline, and 1 (4.2%) was on no antidepressant,
with 1 person on two agents. Of the nonremitted subjects, 16 were
on a SSRI (43.2%), 10 (27.0%) on venlafaxine, 7 (18.9%) on
bupropion, 3 (8.1%) on nortriptyline, 1 (2.7%) on mirtazapine,
and 4 (10.8%) on no antidepressant, with 4 people on two agents.
Using Fisher’s exact test, there was no difference in medication use
between the remitted and nonremitted groups (p=0.8541)
When the trichotomous diagnostic variable was incorporated
into models controlling for age, sex, and total cerebral volume, we
saw no significant relationship between this variable and right
Figure 3. A pair of representative hippocampi are along with
the T1 MRI scan from which the hippocampi were segmented.
doi:10.1371/journal.pone.0001837.g003
Figure 2. The analysis of hippocampus: control vs. depressed.
The distance maps masked by the significance maps are shown on a
pair of representative hippocampi. The scale of color code is illustrated
in a color bar and in millimeters.
doi:10.1371/journal.pone.0001837.g002
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was a statistically significant effect of group in the left hippocampus
(F1,103=5.77, p=0.0043). Using the least squares means analysis,
nondepressed subjects exhibited the largest adjusted mean left
hippocampus volume (3.59mL), while remitted depressed subjects
were slightly smaller (3.54mL) and nonremitted depressed subjects
exhibited the smallest mean volume (3.29mL). Pairwise compar-
isons demonstrated that this difference was statistically significant
between nondepressed and depressed-nonremitted subjects
(p=0.0017), and between depressed-remitted and depressed –
nonremitted subjects (p=0.0159), but not between nondepressed
and depressed-remitted cohorts (p=0.6358).
The visualizations demonstrating group differences are shown
in Figure 4 and Figure 5. There were no statistically significant
differences in shape in the right hippocampus, so only left
hippocampal differences are shown. These analyses primarily
demonstrate a difference in two regions. The first was the same
region identified in the comparison between depressed and
nondepressed control subjects, occurring on the superior surface
midway down the body. Here we see that the same statistically
significant pattern of a central contraction flanked by two regions
of expansion observed between depressed and control subjects is
observed between nonremitted-depressed and control subjects, but
not between control and remitted subjects, or remitted and
nonremitted subjects.
The second large region exhibiting statistically significant
differences in shape is closer to the head, along the lateral
boundary. Here we see that when compared with both remitted
subjects and control subjects, non-remitted subjects exhibit
contraction of this region, which would roughly correspond to
regions CA1 and CA2. This difference was not observed between
remitted and control subjects.
Table 1. Group differences based on diagnosis and remission status
Nondepressed (N=43)
Depressed–Remitted
(N=24)
Depressed–Nonremitted
(N=37) df Test statistic p value
Age (y) 69.0 (5.5) 66.9 (5.7) 65.1 (5.3) 2, 103 F=4.91 0.0092
Sex (% female) 67.4% (29/43) 62.5% (15/24) 59.5% (22/37) 2 x
2=0.51 0.7754
MMSE 28.7 (1.5) 28.3 (3.0) 28.4 (1.8) 2, 103 F=0.40 0.6686
MADRS - 2.0 (2.5) 22.3 (6.4) 49.2 t=17.10 ,0.0001
Age of Onset (y) - 41.5 (21.7) 38.1 (19.1) 59 t=0.56 0.5783
Hippocampus Volume (mL)
- Left 3.55 (0.48) 3.51 (0.62) 3.36 (0.48) 2,103 F=1.42 0.2474
- Right 3.65 (0.55) 3.72 (0.59) 3.60 (0.53) 2, 103 F=1.39 0.2541
Cerebrum Volume (mL) 1571.2 (160.9) 1527.5 (182.7) 1562.9 (171.7) 2, 103 F=0.55 0.5800
MMSE=mini-mental state exam; MADRS=Montgomery-Asberg Depression Rating Scale. All measures presented as mean (standard deviation), except sex. All volumes
presented in milliliters. Differences between groups tested using analysis of covariance (ANCOVA), except for sex, which used the chi square test. Age of onset data were
examined using two-tailed pooled t-tests and MADRS data using a Satterthwaite t-test due to unequal variances. Age of onset and MADRS data were only available for
the depressed population.
doi:10.1371/journal.pone.0001837.t001
Figure 4. The analysis of left hippocampus: control vs.
remitted. The distance maps masked by the significance maps are
shown on a representative hippocampus. The scale of color code is
illustrated in a color bar and in millimeters.
doi:10.1371/journal.pone.0001837.g004
Figure 5. The analysis of left hippocampus: remitted vs. non-
remitted, control vs. non-remitted. The distance maps masked by
the significance maps are shown on a representative hippocampus. The
scale of color code is illustrated in a color bar and in millimeters.
doi:10.1371/journal.pone.0001837.g005
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Although this is not the first study to utilize shape analyses of the
hippocampus in either depression [8] or in an elderly population
[22,33], to our knowledge it is the first to use this technique in an
older population of depressed and nondepressed subjects. In this
study, depressed subjects exhibited both a volumetric difference
and a shape difference in the left hippocampus. This was primarily
due to differences in the nonremitted depressed group, while there
was no difference in hippocampal shape or volume between the
control group and remitted depressed group. Given how we
approached this study with no a priori hypotheses about where we
would expect to see changes, this was an exploratory study and
these results should be considered as being hypothesis-generating.
Numerous studies have examined hippocampal volume in
geriatric depression. Some have reported that depressed elders
exhibit smaller hippocampal volumes [34–36], primarily in the
right hippocampus [12,13,37], while others have found no
difference between depressed and nondepressed elderly cohorts
[16,38]. In contrast, our current report identified a reduction in
the volume of the left hippocampus, but not the right. Possible
explanations for these conflicting findings include methodological
issues, such as different hippocampal boundary definitions, or
differences in image acquisition–such as our use of 3T MRI, which
offers improved image resolution. Differences in clinical factors
also become important, such as differences in age, duration of
depression [4], or antidepressant treatment [39].
Far fewer studies have examined hippocampal shape. A study of
hippocampal shape in a younger adult cohort of depressed and
nondepressed subjects identified depression-related deformation of
the subiculum [8]. Our study excluded subjects with dementia, but
finding of differences in the subiculum have also been observed in
subjects with dementia of Alzheimer’s type (DAT) [24], although
DAT subjects exhibit more widespread changes in the CA1
region, which encompasses much of the head and lateral aspect of
the hippocampus. DAT may also be associated with changes in the
dentate gyrus, and possibly parts of CA2 or CA3 [22], which is
comparable to our current findings. Also similar to our findings,
shape differences in DAT may be more apparent in the left
hippocampus than right [22,23].
These similarities support theories associating depression and
DAT. There are a number of studies supporting an association
between a lifetime history of depression with an increased risk of
DAT [40–44]. Both duration and number of depressive episodes is
associated with smaller hippocampal volumes [4,12], while smaller
left hippocampal volume in older depressed individuals is
associated with a greater risk of dementia [18]. Moreover, a
lifetime history of depression is associated with greater DAT-
related neuropathological changes in the hippocampus [45].
Given how the risk of DAT increases with age, this also raises
the issue that there was a significant difference in age between our
diagnostic groups. Since the mean difference was only 3.1 years,
and the nondepressed cohort was older, it is unlikely that the age
difference is responsible for the observed shape differences.
However, there is the possibility the study included subjects who
had no obvious clinical symptoms of Alzheimer disease but were
early in the process of its development.
The majority of volumetric and shape differences observed
between depressed and nondepressed subjects appear to be
primarily driven by the nonremitted depressed group. In analyses
where the depressed cohort was divided into remitted and
nonremitted subjects, there were widespread differences between
nonremitted and control subjects, and nonremitted and remitted
subjects, but only isolated, small differences in shape between
remitted and control subjects. Although there are no previously
published analyses of hippocampus shape between remitted and
nonremitted depressed subjects, our volumetric findings are
similar to previously reported volumetric studies [5,46].
As this is a cross-sectional study, we cannot determine the causal
relationship between remission status and our hippocampus finding.
Individuals with greater hippocampal abnormalities may be less
likely to achieve remission [17]. Alternatively, remission of
depression may be associated with correction of the hippocampal
shape and volumetric differences seen in depressed subjects who are
currently symptomatic. If this second hypothesis is correct, this
correction of hippocampal structure may be secondary to antide-
pressants, which are thought to affect hippocampal volume through
neurogenesis [39], although this has not been conclusively
demonstrated [47]. It is possible that antidepressant use in particular
may be related toourfindings ofa depression-related expansion seen
in the vicinity of the dentate gyrus. The dentate gyrus is a specific
region of the hippocampusthat continues to give riseto new neurons
throughout adult life; this production may be inhibited by stress or
increased glucocorticoid levels, while trophic factors and serotonin
may increase this production [39]. Thus our findings of contraction
of the dentate gyrus in nonremitted depressed subjects when
compared with control subjects, while remitted subjects do not
differfrom control subjects,may berelated to theneurotrophiceffect
of antidepressant medications when accompanied by remission of
symptoms. Clearly such a hypothesis requires further study.
The study has limitations that should be noted, including our
definition of the hippocampus. Our measure does not include the
moreposteriorcomponentofthebodynorthetail.Thusourfindings
are only applicable to the head and anterior body. A second
limitation of our results is the absence of a correction for multiple
comparisons. With our image analysis technique, methods correct-
ing for multiple comparison based family wise errors often result in a
major overcorrection and highly reduced sensitivity, as they
eliminate many effects that are found at the p,0.05 level. However
the hippocampal volumetric measures reported do not have this
limitation and support the shape conclusions. Even with this
potential limitation, the shape results we are reporting should be of
strong interest to the community to illustrate the potential of shape
analysis methods and despite being exploratory, these results provide
crucial data for future studies. A third limitation was in the clinical
assessments, as there was not a more thorough analysis of depression
history,suchaslifetimedurationofdepressivesymptoms,whichitself
has been associated with hippocampal volume differences [4].
Although we saw no significant difference between remitted and
nonremitted subjects on age of depression onset or current
antidepressant use, these assessments do not capture the longer
term duration of depression. Additionally, the samples were not
matched for potential differences such as handedness, and even
differed in age which itself has an effect on brain structure.
This study demonstrates a left-hemisphere difference in hippo-
campal shape between elderly depressed and nondepressed subjects,
primarily due to the effect of the nonremitted depressed subjects in
our cohort. These differences may be related to the relationship
between depression and risk of dementia or historical course of
depression. Moreover, genetic polymorphisms of the serotonin
transporter-linked promoter region (5HTTLPR) and brain derived
neurotrophic region (BDNF) genes have been linked with depression
and hippocampal volume differences, and should be considered in
future studies as these and similar polymorphisms may have
contributed to the differences observed in this study.. Further work
using longitudinal designs, with comprehensive assessments of
depression history, and in subjects who are antidepressant-free, is
needed to better examine the hypotheses generated by this study.
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